Both subcutaneously and intravenously administered glucagon-like peptide 1 are rapidly degraded from the NH2-terminus in type 2 diabetic patients and in healthy subjects. - Deacon,C.F.; Nauck,M.A.; Toft-Nielsen,M.; Pridal,L.; Willms,B.; Holst,J.J. (Diabetes, 1995)